China CDC http://www.chinacdc.cn/en/
National Health Commission of the People’s Republic of China [to 29 Jan 2022]
Jan 29: Daily briefing on novel coronavirus cases in China
On Jan 28, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 59 new cases of confirmed infections.
Beijing upgrades measures to stem latest COVID-19 resurgence
… Li Ang, deputy director of the Beijing Municipal Health Commission, said that Beijing had classified one new area in the district as medium-risk for COVID-19, which brought the number of medium-risk areas in the city to seven. Beijing also has one high-risk area.
On the basis of existing prevention and control measures in affected areas of Fengtai, the district government has rolled out a series of new measures including restrictions on leaving affected areas, daily nucleic acid testing, and encouraging telecommuting.
National Medical Products Administration – PRC [to 29 Jan 2022]
Nearly 2.99b COVID-19 vaccine doses administered on Chinese mainland
Nearly 2.99 billion COVID-19 vaccine doses had been administered on the Chinese mainland as of Thursday, data from the National Health Commission showed on Jan 28.
CCDC Weekly Reports: Current Volume (4)
2022-01-28 / No. 4 COVID-19 ISSUE (22)
View PDF of this issue
Preplanned Studies: Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence — China, 2021
Preplanned Studies: Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
Perspectives: Bubble Strategy — A Practical Solution to Return to Regular Life in the Intertwined Era of Vaccine Rollouts and Virus Mutation
Perspectives: The Dynamic COVID-Zero Strategy in China
Notes from the Field: The First Two Imported Cases of SARS-CoV-2 Omicron Variant — Tianjin Municipality, China, December 13, 2021